The story has been updated to include comments from Exact Sciences' conference call this morning.

NEW YORK (GenomeWeb) – Exact Sciences today reported no revenues for the second quarter as it awaits a decision from the US Food and Drug Administration on its Cologuard premarket approval submission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.